Clinical Trial Update: Efficacy and Safety of Acetylcysteine for the Treatment of Acute Uncomplicated Rhinosinusitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating acetylcysteine for acute uncomplicated rhinosinusitis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis

Drugs mentioned

• Acetylcysteine (Acetylcysteine)

Snippet

Sponsor: Sandoz | Conditions: Rhinosinusitis | Phase 3 | Status: COMPLETED | Results posted: 2021-11-19